Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma. [electronic resource]
- International immunopharmacology Aug 2003
- 1169-76 p. digital
Publication Type: Journal Article; Review
1567-5769
10.1016/S1567-5769(03)00012-2 doi
Adjuvants, Immunologic--therapeutic use Antiviral Agents--therapeutic use Carcinoma, Hepatocellular--prevention & control Clinical Trials as Topic Drug Therapy, Combination Hepatitis B, Chronic--complications Hepatitis C, Chronic--complications Hepatitis, Viral, Human--complications Humans Liver Neoplasms--prevention & control Thymalfasin Thymosin--analogs & derivatives